McKesson Corp. - Providence Business News

Home Tags McKesson Corp.

ATTORNEY GENERAL PETER F. NERONHA announced on Jan. 25 that Rhode Island settled lawsuits related to the opioid crisis with multinational corporation Johnson & Johnson and pharmaceutical distributors Cardinal Health Inc., McKesson Corp. and AmerisourceBergen Corp. for a total of $114 million. / SCREENSHOT OF PRESS CONFERENCE ON WPRI-TV CBS 12

R.I. to get $114 million from opioid lawsuit settlements

Government 01/25/2022

PROVIDENCE – Attorney General Peter F. Neronha announced on Tuesday that his office reached a $9.8 million settlement with American multinational corporation Johnson &...

MCKESSON CORP., Cardinal Health Inc. and AmerisourceBergen Corp. have proposed paying $10 billion to settle claims they helped to fuel the United States opioid epidemic. / BLOOMBERG NEWS FILE PHOTO/DHIRAJ SINGH

Opioid distributors propose $10B to end state claims

Government 08/06/2019

WILMINGTON, Del. – McKesson Corp., Cardinal Health Inc. and AmerisourceBergen Corp. have proposed paying $10 billion to settle claims they helped to fuel the...

CVS DISTRIBUTED 7.7% of all opioid pills in the U.S. between 2006 and 2012, according to newly available data from the DEA. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE

WaPo: Opioid distributors, including CVS, cited in DEA data

Economic Activity 07/17/2019

PROVIDENCE – There were 76 billion opioid pills distributed in the United States over a seven-year period from 2006 to 2012, according to a...

- Featured Event -

Latest News

Study: Providence ranks 20th among Northeastern tech metros

10/03/2023

Biocomposites supplier wins PitchRI contest

10/03/2023

Innovation lab opens at Boys & Girls Club of Pawtucket

10/03/2023

Smartapp.com, SAP Store enter into new construction tech partnership

10/03/2023

Portsmouth home along Sakonnet River sells for record $8.55M

10/03/2023

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.